Citation Impact
Citing Papers
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
2007 Standout
The gut microbiota influences blood-brain barrier permeability in mice
2014 Standout
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Obesity alters gut microbial ecology
2005 Standout
Meta‐analysis: vasoactive medications for the management of acute variceal bleeds
2012
Metagenomic Analysis of the Human Distal Gut Microbiome
2006 StandoutScience
The gut microbiota and host health: a new clinical frontier
2015 Standout
Why portal hypertensive varices bleed and bleed: a hypothesis.
1995
UK guidelines on the management of variceal haemorrhage in cirrhotic patients
2015
Small intestinal transit in patients with liver cirrhosis and portal hypertension: a descriptive study
2012
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Decompensated Cirrhotics Have Slower Intestinal Transit Times as Compared With Compensated Cirrhotics and Healthy Controls
2013
Oral Bile Acids Reduce Bacterial Overgrowth, Bacterial Translocation, and Endotoxemia in Cirrhotic Rats
2003
Delayed gastrointestinal transit in patients with hepatocellular carcinoma
2002
Role of gastric sensorimotor dysfunction in gastrointestinal symptoms and energy intake in liver cirrhosis
2006
Enteral Versus Parenteral Feeding Effects on Septic Morbidity After Blunt and Penetrating Abdominal Trauma
1992 Standout
Verapamil
1989
Intestinal microflora in patients with liver cirrhosis
2004
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
2015 StandoutNature
Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia
2002
Toll-like receptors as targets in chronic liver diseases
2009
Infections in Patients With Cirrhosis Increase Mortality Four-Fold and Should Be Used in Determining Prognosis
2010
Transfusion Strategies for Acute Upper Gastrointestinal Bleeding
2013 Standout
Burden of liver diseases in the world
2018 Standout
Budd-Chiari Syndrome Secondary to Antiphospholipid Syndrome
2001
The role of the gut microbiota in nonalcoholic fatty liver disease
2010
Gut biogeography of the bacterial microbiota
2015 Standout
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
2012 StandoutNature
TLR4 enhances TGF-β signaling and hepatic fibrosis
2007 Standout
Small Intestine Dysmotility and Bacterial Overgrowth in Cirrhotic Patients With Spontaneous Bacterial Peritonitis
1998
Altered Small Bowel Motility in Patients with Liver Cirrhosis Depends on Severity of Liver Disease
1997
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
2009 Standout
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
Hepatocellular carcinoma
2021 Standout
Hepatic circulation: Potential for therapeutic intervention
1990
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
2021 Standout
Vascular disorders of the liver # †
2008 Standout
A Panel of Cytochrome P450 BM3 Variants to Produce Drug Metabolites and Diversify Lead Compounds
2009 StandoutNobel
Pathological bacterial translocation in liver cirrhosis
2013
Design considerations for tumour-targeted nanoparticles
2009 StandoutNobel
Portal hypertensive bleeding in cirrhosis
2016 Standout
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
2019 Standout
Altered intestinal function precedes the appearance of bacterial DNA in serum and ascites in patients with cirrhosis: a pilot study
2010
Toll-Like Receptor Signaling in the Liver
2006
Intestinal barrier dysfunction in developing liver cirrhosis: An in vivo analysis of bacterial translocation
2007
Small‐intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease
2009
Investigation of Autonomic Function and Orocecal Transit Time in Patients With Nonalcoholic Cirrhosis and the Potential Influence of These Factors on Disease Outcome
2009
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Autonomic Dysfunction and Gastroparesis in Cirrhosis
2003
Intestinal permeability in cirrhotic patients with and without ascites
2005
Acute and long-term effects of inhaled iloprost in portopulmonary hypertension
2010
Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients
1995
Etiology of portal hypertension may influence gastrointestinal transit
2003
Gut flora in health and disease
2003 Standout
Assessment of Intestinal Permeability and Absorption in Cirrhotic Patients with Ascites Using Combined Sugar Probes
2004
Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis
2000
Pulmonary–Hepatic vascular Disorders (PHD)
2004
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
UK guidelines on the management of variceal haemorrhage in cirrhotic patients
2000
Incorporating indocyanin green clearance into the Model for End Stage Liver Disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis
2010
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
2016 Standout
Gastrointestinal symptoms in patients with liver cirrhosis: Associations with nutritional status and health-related quality of life
2006
Disordered Gastric Motor Function in Diabetes Mellitus: Recent Insights into Prevalence, Pathophysiology, Clinical Relevance, and Treatment
1991
Assessment of acute pulmonary vascular reactivity in portopulmonary hypertension
2007
The Effect of Exercise on the Gastrointestinal Tract1
1990
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Gastrointestinal dysfunction in liver cirrhosis
2014
Early Enteral Feeding, Compared With Parenteral, Reduces Postoperative Septic Complications The Results of a Meta-Analysis
1992 Standout
Spontaneous bacterial empyema in cirrhotic patients: A prospective study
1996
Gut Transit Is Associated With Gastrointestinal Symptoms and Gut Hormone Profile in Patients With Cirrhosis
2008
Bacterial DNA Translocation Is Associated With Systemic Circulatory Abnormalities and Intrahepatic Endothelial Dysfunction in Patients With Cirrhosis
2010
Role of intestinal bacterial overgrowth and intestinal motility in bacterial translocation in experimental cirrhosis
2005
Small Intestinal Motility Disturbances and Bacterial Overgrowth in Patients With Liver Cirrhosis and Portal Hypertension
2003
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Diabetes Mellitus Is Associated with Hepatic Encephalopathy in Patients with HCV Cirrhosis
2006
Bacterial translocation (BT) in cirrhosis†
2005
Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy
2010
Continuous prazosin administration in cirrhotic patients: Effects on portal hemodynamics and on liver and renal function
1995
The human microbiome: at the interface of health and disease
2012 Standout
The treatment of portal hypertension: A meta-analytic review
1995
Pulmonary Arterial Hypertension in France
2006 Standout
Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients.
1996 Standout
Liver Function Assessment by Drug Metabolism
1990
Gut Microbiota in Health and Disease
2010 Standout
Gut flora and bacterial translocation in chronic liver disease
2006
Dialogue between E. coli free radical pathways and the mitochondria of C. elegans
2015 StandoutNobel
The Hidden World within Plants: Ecological and Evolutionary Considerations for Defining Functioning of Microbial Endophytes
2015 Standout
Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma
2020
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
2008 Standout
The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension
2012
Introduction to the human gut microbiota
2017 Standout
Inflammatory Bowel Disease
2010 Standout
ACSM Position Stand: The Recommended Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory and Muscular Fitness, and Flexibility in Healthy Adults
1998 Standout
The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota
2017 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites
1997
Pleural Effusion
2002 Standout
Diabetic Autonomic Neuropathy
2003 Standout
ACSM Position Stand: Exercise and Fluid Replacement
1996 Standout
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
1998 Standout
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Works of J Chesta being referenced
Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis
1989
Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis
1989
Steady-State Extrarenal Sorbitol Clearance as a Measure of Hepatic Plasma Flow
1988
Effects of vasopressin on the intravariceal pressure in patients with cirrhosis: Comparison with the effects on portal pressure
1988
Effects of verapamil on hepatic and systemic hemodynamics and liver function in patients with cirrhosis and portal hypertension
1988
Delayed stomach to caecum transit time in the diabetic rat. Possible role of hyperglucagonaemia.
1990
[Spontaneous bacterial peritonitis: a frequent and recurrent complication in cirrhotic patients with ascites].
1991
[Post sinusoidal obstruction of the hepatic venous flow associated with antiphospholipid syndrome in 3 cases].
1993
Octreotide reduces azygos blood flow in cirrhotic patients with portal hypertension
1990
[Are disturbances of small intestinal motility associated with hyperglucagonemia in patients with liver cirrhosis?].
1992
[Spontaneous bacterial pleuritis in 3 patients with liver cirrhosis].
1991
Abnormalities in proximal small bowel motility in patients with cirrhosis
1993
[Bacterial overgrowth in small intestine in patients with liver cirrhosis].
1991
[Morphology of the myenteric plexus of the small intestine in patients with liver cirrhosis].
1993
[Microscopic colitis and collagenous colitis. An entity not yet reported in Chile].
1992
[Patients with liver cirrhosis: mouth-cecum transit time and gastric emptying of solid foods].
1991